The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-Bromobenzyl)-5-phenyl-1-oxa-5-azaspiro[5.5]undeca-7,10-diene-4,9-dione ID: ALA4525287
PubChem CID: 135365427
Max Phase: Preclinical
Molecular Formula: C22H18BrNO3
Molecular Weight: 424.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C1C=CC2(C=C1)OCC(Cc1ccc(Br)cc1)C(=O)N2c1ccccc1
Standard InChI: InChI=1S/C22H18BrNO3/c23-18-8-6-16(7-9-18)14-17-15-27-22(12-10-20(25)11-13-22)24(21(17)26)19-4-2-1-3-5-19/h1-13,17H,14-15H2
Standard InChI Key: VVAXZJMJNUFXRL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
19.3732 -3.3761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3691 -2.5548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6591 -2.1520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9487 -2.5619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9528 -3.3832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6674 -3.7946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3732 -4.1974 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0826 -4.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7920 -4.1974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7920 -3.3761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0826 -2.9592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5051 -2.9696 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2395 -2.1559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0831 -2.1387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7965 -1.7307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7969 -0.9102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0845 -0.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3703 -0.9138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3735 -1.7330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5033 -4.6111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2157 -4.1994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9253 -4.6141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6331 -4.2031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6347 -3.3809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9226 -2.9714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2136 -3.3806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3466 -2.9724 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
1 7 1 0
1 11 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
10 12 2 0
4 13 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
11 14 1 0
9 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 424.29Molecular Weight (Monoisotopic): 423.0470AlogP: 4.06#Rotatable Bonds: 3Polar Surface Area: 46.61Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.28CX LogD: 5.28Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.75Np Likeness Score: 0.14
References 1. Venkanna A, Cho KH, Dhorma LP, Kumar DN, Hah JM, Park HG, Kim SY, Kim MH.. (2019) Chemistry-oriented synthesis (ChOS) and target deconvolution on neuroprotective effect of a novel scaffold, oxaza spiroquinone., 163 [PMID:30530196 ] [10.1016/j.ejmech.2018.11.037 ]